Back to SNDX

Aisling Capital Management LP → SNDX

Aisling Capital Management LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$24.8M
Q3 2026
Peak value
$30.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$27.7M
Q1 2026$30.8M
Q2 2026$28.8M
Q3 2026$24.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$24.8M1.32M——
Q2 2026$28.8M1.32M——
Q1 2026$30.8M1.32M——
Q4 2025$27.7M1.32M——

Other funds holding SNDX

Other Aisling Capital Management LP positions

BBIO

BridgeBio Pharma Inc. (BBIO)

$389.3M
BBIO

BridgeBio Pharma Inc. (BBIO)

$378M
BBIO

BRIDGEBIO PHARMA INC

$341.8M
BBIO

BRIDGEBIO PHARMA INC

$203.3M
MNST

MONTE ROSA THERAPEUTICS INC

$37.6M
MNST

Monte Rosa Therapeutics Inc (GLUE)

$25.6M
MNST

Monte Rosa Therapeutics Inc (GLUE)

$23.1M
CMPS

COMPASS PATHWAYS PLC

$21.6M